Consumers don't seem to mind puffing away their money -- or, alternately, smoking away their economic woes -- which was good news for cig-maker Altria ( MO).

The seller of Marlboro cigarettes and Black & Mild cigars posted a 9% jump in second quarter earnings, boosted by cost cuts, the acquisition of a smokeless tobacco maker, and improved sales of both cigarettes and cigars.

The good news prompted Altria to lifts its full-year outlook.

During the quarter, the company earned $1.01 billion, or 49 cents a share, compared with $930 million, or 45 cents, in the year-ago period. Excluding exit costs related to plant closings and other items, its earnings were 50 cents per share. Analysts had expected a profit of 47 cents.

The company's revenue shot up 33% to $6.72 billion from $5.05 billion. Altria attributed the gain to a federal excise tax increase and its purchase of smokeless tobacco-maker UST in January.

Altria managed to lower corporate expenses to $50 million from $73 million.

Like most cigarette makers, Altria raised prices earlier this year ahead of a federal tax increase, and it seems as a result its Philip Morris brand lost some market share.

Philip Morris shipped 40.6 billion cigarettes during the quarter, down 6.8% from last year.

Looking ahead, the company now expects to earn between $1.72 and $1.77 a share during the year, up from its previous guidance in the range of $1.70 to $1.75 a share.
Copyright 2009 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

If you liked this article you might like

The Really Big Money Rushes to Super Bowl

The Really Big Money Rushes to Super Bowl

CDC Director Steps Down Following Report She Invested in Big Tobacco Stocks

CDC Director Steps Down Following Report She Invested in Big Tobacco Stocks

Immunotherapy M&A In Focus as Celgene Buys Juno; Good, Bad of Activism--ICYMI

Immunotherapy M&A In Focus as Celgene Buys Juno; Good, Bad of Activism--ICYMI

Are Politics and Proxy Firms Killing Your Investment Returns?

Are Politics and Proxy Firms Killing Your Investment Returns?

Hot Biotech ETF Finally Flashes Buy Signal

Hot Biotech ETF Finally Flashes Buy Signal